Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Agomelatine for generalized anxiety disorder (non-depressed outpatients)
2008-003421-17Phase 3Terminated
- Sponsor
- Servier
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of agomelatine in generalized anxiety disorder (GAD) (3 arms), sponsored by Servier. Started Dec 2008; status: terminated.
02
Drugs
agomelatine
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on 2008-003421-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003421-17.